Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
Saved in:
| Title: | Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. |
|---|---|
| Authors: | Jardine MJ; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.; Concord Repatriation General Hospital, Concord, NSW, Australia., Kotwal SS; The George Institute for Global Health, University of New South Wales, Newtown, NSW, Australia.; Prince of Wales Hospital, Randwick, NSW, Australia., Bassi A; The George Institute for Global Health, UNSW, New Delhi, India., Hockham C; The George Institute for Global Health, Imperial College London, UK., Jones M; Sydney School of Public Health, University of Sydney, Camperdown, NSW, Australia., Wilcox A; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia arlen.wilcox@sydney.edu.au., Pollock C; Royal North Shore Hospital, St Leonards, NSW, Australia.; Kolling Institute of Medical Research, University of Sydney, St Leonards, NSW, Australia., Burrell LM; Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.; Institute of Breathing and Sleep, Heidelberg, VIC, Australia., McGree J; Queensland University of Technology, Brisbane, QLD, Australia., Rathore V; All India Institute of Medical Sciences, Raipur, India., Jenkins CR; Concord Repatriation General Hospital, Concord, NSW, Australia.; The George Institute for Global Health, University of New South Wales, Newtown, NSW, Australia., Gupta L; Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India., Ritchie A; Concord Repatriation General Hospital, Concord, NSW, Australia., Bangi A; Jivanrekha Multispecialty Hospital, Pune, India., D'Cruz S; Government Medical College and Hospital, Chandigarh, India., McLachlan AJ; Sydney Pharmacy School, The University of Sydney, Camperdown, NSW, Australia., Finfer S; The George Institute for Global Health, University of New South Wales, Newtown, NSW, Australia., Cummins MM; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia., Snelling T; The Sydney Children's Hospitals Network, Westmead, NSW, Australia., Jha V; The George Institute for Global Health, UNSW, New Delhi, India.; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.; School of Public Health, Imperial College, London, UK. |
| Corporate Authors: | CLARITY trial investigators |
| Source: | BMJ (Clinical research ed.) [BMJ] 2022 Nov 16; Vol. 379, pp. e072175. Date of Electronic Publication: 2022 Nov 16. |
| Publication Type: | Adaptive Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Pragmatic Clinical Trial; Randomized Controlled Trial |
| Journal Info: | Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36384746 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jardine+MJ%22">Jardine MJ</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.; Concord Repatriation General Hospital, Concord, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Kotwal+SS%22">Kotwal SS</searchLink>; The George Institute for Global Health, University of New South Wales, Newtown, NSW, Australia.; Prince of Wales Hospital, Randwick, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Bassi+A%22">Bassi A</searchLink>; The George Institute for Global Health, UNSW, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Hockham+C%22">Hockham C</searchLink>; The George Institute for Global Health, Imperial College London, UK.<br /><searchLink fieldCode="AU" term="%22Jones+M%22">Jones M</searchLink>; Sydney School of Public Health, University of Sydney, Camperdown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Wilcox+A%22">Wilcox A</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia arlen.wilcox@sydney.edu.au.<br /><searchLink fieldCode="AU" term="%22Pollock+C%22">Pollock C</searchLink>; Royal North Shore Hospital, St Leonards, NSW, Australia.; Kolling Institute of Medical Research, University of Sydney, St Leonards, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Burrell+LM%22">Burrell LM</searchLink>; Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.; Institute of Breathing and Sleep, Heidelberg, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22McGree+J%22">McGree J</searchLink>; Queensland University of Technology, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Rathore+V%22">Rathore V</searchLink>; All India Institute of Medical Sciences, Raipur, India.<br /><searchLink fieldCode="AU" term="%22Jenkins+CR%22">Jenkins CR</searchLink>; Concord Repatriation General Hospital, Concord, NSW, Australia.; The George Institute for Global Health, University of New South Wales, Newtown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Gupta+L%22">Gupta L</searchLink>; Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Ritchie+A%22">Ritchie A</searchLink>; Concord Repatriation General Hospital, Concord, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Bangi+A%22">Bangi A</searchLink>; Jivanrekha Multispecialty Hospital, Pune, India.<br /><searchLink fieldCode="AU" term="%22D'Cruz+S%22">D'Cruz S</searchLink>; Government Medical College and Hospital, Chandigarh, India.<br /><searchLink fieldCode="AU" term="%22McLachlan+AJ%22">McLachlan AJ</searchLink>; Sydney Pharmacy School, The University of Sydney, Camperdown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Finfer+S%22">Finfer S</searchLink>; The George Institute for Global Health, University of New South Wales, Newtown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Cummins+MM%22">Cummins MM</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Snelling+T%22">Snelling T</searchLink>; The Sydney Children's Hospitals Network, Westmead, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Jha+V%22">Jha V</searchLink>; The George Institute for Global Health, UNSW, New Delhi, India.; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.; School of Public Health, Imperial College, London, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22CLARITY+trial+investigators%22">CLARITY trial investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228900488%22">BMJ (Clinical research ed.)</searchLink> [BMJ] 2022 Nov 16; Vol. 379, pp. e072175. <i>Date of Electronic Publication: </i>2022 Nov 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Adaptive Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Pragmatic Clinical Trial; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Association%22">British Medical Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8900488 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-1833 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598138%22">09598138 </searchLink><i>NLM ISO Abbreviation: </i>BMJ <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36384746 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/bmj-2022-072175 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e072175 Titles: – TitleFull: Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jardine MJ – PersonEntity: Name: NameFull: Kotwal SS – PersonEntity: Name: NameFull: Bassi A – PersonEntity: Name: NameFull: Hockham C – PersonEntity: Name: NameFull: Jones M – PersonEntity: Name: NameFull: Wilcox A – PersonEntity: Name: NameFull: Pollock C – PersonEntity: Name: NameFull: Burrell LM – PersonEntity: Name: NameFull: McGree J – PersonEntity: Name: NameFull: Rathore V – PersonEntity: Name: NameFull: Jenkins CR – PersonEntity: Name: NameFull: Gupta L – PersonEntity: Name: NameFull: Ritchie A – PersonEntity: Name: NameFull: Bangi A – PersonEntity: Name: NameFull: D'Cruz S – PersonEntity: Name: NameFull: McLachlan AJ – PersonEntity: Name: NameFull: Finfer S – PersonEntity: Name: NameFull: Cummins MM – PersonEntity: Name: NameFull: Snelling T – PersonEntity: Name: NameFull: Jha V IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 11 Text: 2022 Nov 16 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1756-1833 Numbering: – Type: volume Value: 379 Titles: – TitleFull: BMJ (Clinical research ed.) Type: main |
| ResultId | 1 |